{
  "id": "PD_QT_ADDITIVE",
  "name": "Additive QT prolongation risk with multiple QT-prolonging drugs",
  "domain": "PD",
  "severity": "major",
  "logic": {
    "pd_overlap": { "effect_id": "QT_prolongation", "min_magnitude": "medium" },
    "rationale": [
      "Both drugs contribute to QT prolongation risk domain.",
      "Combined effects can increase torsades risk, especially with additional risk factors."
    ]
  },
  "explanation_template": "{A_name} and {B_name} both have QT-prolongation liability. Using them together can increase QT-related risk. Patient-specific factors (electrolytes, baseline QT, bradycardia, other QT drugs) strongly modify real-world risk.",
  "references": [
    { "source": "Educational note", "citation": "PD stacking: shared QT domain implies additive risk." }
  ]
}

